Coronavirus vaccine could be ready by October: Pfizer CEO claims
By MYBRANDBOOK
Pfizer’s CEO Albert Bourla said the company is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech. Bourla said this while participating at a webinar by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week.
“If things go well and the stars are aligned, we will have enough evidence of safety and efficacy for us to feel comfortable, for the FDA (US Food and Drug Administration) to feel comfortable, and for the EMA (European Medicines Agency) to feel comfortable, to have a vaccine around the end of October,” Bourla was quoted as saying at the event by FierceBiotech. While GSK has joined forces with Sanofi, AstraZeneca is backing the vaccine being developed at the University of Oxford.
Pfizer is working with German firm BioNTech for several possible vaccines in Europe and the United States, said the report.
Besides, the report also quoted AstraZeneca boss who said that one or more vaccines could begin rolling out by the end of the year. AstraZeneca, in partnership with the University of Oxford, is working to come up with a vaccine and expects at least one could be ready by the end of 2020.
"The hope of many people is that we will have a vaccine, hopefully several, by the end of this year,” Pascal Soriot, head of AstraZeneca, was quoted in the report as saying. He, however, said “we are running against time".
The report also highlighted the warnings from experts saying the challenges could be "daunting" as the estimates show that about 15 million doses would be required to stop the pandemic.
According to the report, Soriot said that one of the challenges in coming up with a vaccine was declining transmission rates as it will be difficult "to properly conduct clinical vaccine trials in a natural setting".
According to the report, more than 100 labs across the world are working to develop a vaccine against the deadly virus. Of these, ten have made it to the clinical trial stage.
The deadly virus has killed over 358,000 people and infected more than five million worldwide so far.
Nazara and ONDC set to transform in-game monetization with ‘
Nazara Technologies has teamed up with the Open Network for Digital Comme...
Jio Platforms and NICSI to offer cloud services to government
In a collaborative initiative, the National Informatics Centre Services In...
BSNL awards ₹5,000 Cr Project to RVNL-Led Consortium
A syndicate led by Rail Vikas Nigam Limited (abbreviated as RVNL), along wi...
Pinterest tracks users without consent, alleges complaint
A recent complaint alleges that Pinterest, the popular image-sharing platf...
TECHROUTES NETWORK PRIVATE LIMITED
DRUVA SOFTWARE PVT. LTD.
FIRE BOLTT
HP INDIA SALES PVT. LTD.
Icons Of India : Arundhati Bhattacharya
Arundhati Bhattacharya serves as the Chairperson and CEO of Salesforce...
ICONS OF INDIA : SUNIL BHARTI MITTAL
Sunil Bharti Mittal is the Founder and Chairman of Bharti Enterprises,...
Icons Of India : Debjani Ghosh
Debjani Ghosh is the President of the National Association of Software...
IOCL - Indian Oil Corporation Ltd.
IOCL is India’s largest oil refining and marketing company ...
C-DAC - Centre for Development of Advanced Computing
C-DAC is uniquely positioned in the field of advanced computing...
PFC - Power Finance Corporation Ltd
PFC is a leading financial institution in India specializing in power ...
Indian Tech Talent Excelling The Tech World - ARVIND KRISHNA, CEO – IBM
Arvind Krishna, an Indian-American business executive, serves as the C...
Indian Tech Talent Excelling The Tech World - NIKESH ARORA, Chairman CEO - Palo Alto Networks
Nikesh Arora, the Chairman and CEO of Palo Alto Networks, is steering ...
Indian Tech Talent Excelling The Tech World - Lal Karsanbhai, President & CEO, Emerson
Lal Karsanbhai, President and CEO of Emerson, assumed the leadership i...